The purpose of the present study was to assess the influence of local and systemic factors on the occurrence of dental implant failures up to the second-stage surgery (abutment connection). This retrospective study is based on 2,670 patients who received 10,096 implants and were consecutively treated with implant-supported prostheses between 1980 and 2014 at 1 specialist clinic. Several anatomic-, patient-, health-, and implant-related factors were collected. Descriptive statistics were used to describe the patients and implants. Univariate and multivariate logistic regression models were used at the patient level as well as the implant level to evaluate the effect of explanatory variables on the failure of implants up to abutment connection. A generalized estimating equation method was used for the implant-level analysis to account for the fact that repeated observations (several implants) were available for a single patient. Overall, 642 implants (6.36%) failed, of which 176 (1.74%) in 139 patients were lost up to second-stage surgery. The distribution of implants in sites of different bone quantities and qualities was quite similar between implants lost up to and after abutment connection. Smoking and the intake of antidepressants were the statistically significant predictors in the multivariate model (ClinicalTrials.gov NCT02369562).
Introduction
Nowadays dental implant placement is an effective and predictable treatment modality for replacing missing teeth in fully and partially edentulous patients. Nevertheless, failures still happen despite high implant survival and success rates (Chrcanovic et al. 2014) . Failures of dental implants can be subdivided into early and late failures, depending on whether they occur before or at abutment connection surgery (early) or after occlusal loading by a prosthetic restoration (late). This subdivision is relevant because it suggests that failures in these 2 distinct periods may be associated with different factors. An early failure of an implant results from an inability to establish an intimate bone-to-implant contact. In this case, bone healing after implant insertion is impaired and may be influenced by local and systemic factors (Alsaadi et al. 2007 ). Systemic diseases and compromising risky habits may affect oral tissues by increasing their susceptibility to other diseases or by interfering with wound healing. Surgical conditions, submission to radiotherapy, and the intake of medications by the patient may play a role on the outcome of implants. When it comes to late implant failures, oral microbial environment, parafunctional habits, and prosthetic rehabilitation variables are also taken into account. Although many studies have shown the influence of local and systemic factors in the long-term outcome of dental implants (Chrcanovic et al. 2014) , less is known concerning the factors affecting the initial phases of osseointegration. The aim of the present study was to assess the influence of local and systemic factors on the occurrence of implant failures up to second-stage surgery (abutment connection).
Materials and Methods

Materials
This retrospective study is based on all 2,670 patients who received 10,096 implants and were consecutively treated with implant-supported prostheses between 1980 and 2014 at 1 specialist clinic (Clinic for Prosthodontics, Centre of Dental Specialist Care, Malmö, Sweden). The study was approved by the Regional Ethical Review Board in Lund (Dnr 2014 /598, Dnr 2015 ). This study is in concordance with the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines for observational studies.
Inclusion and Exclusion Criteria
All implants that had failed up to second-stage surgery (abutment connection) were included. Therefore, there is a minimum risk of selection bias, since all implants with early failure were selected from all implants ever inserted in this clinic. 646098J DRXXX10.1177/0022034516646098Journal of Dental ResearchEarly Dental Implant Failures
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Only modern endosseous dental implants with cylindrical or conical design were considered. Zygomatic implants were not included in the study, as well as implants that were detected in radiographies, but that did not have basic information about them in the patients' files.
Definitions
An implant was considered a failure if presenting signs and symptoms led to implant removal. Thus, a failed implant in our study is equal to a lost implant.
Data Collection
The following data were collected: implant surface (turned/ machined or enlarged surfaces, the latter including sandblasted, acid-etched, sandblasted + acid-etched, anodized, hydroxyapatitecoated surfaces), implant system (Nobel turned, Nobel TiUnite, Astra TiOblast, Astra Osseospeed, Straumann SLA/SLActive/ Roxlid, XIVE/Frialit-2, other), implant length and diameter, implant design (cylindrical or conical), prescription of antibiotics (the prophylactic antibiotic regimen usually started 1 to 2 h before surgery and went from 5 to 7 d postoperatively), bone graft procedures, reason for tooth extraction (periodontal disease, fracture/trauma, advanced caries, agenesia, other), implant jaw location (maxilla or mandible), number of implants in maxilla or mandible, anterior or posterior location of the implant (locations between 13 and 23 and between 33 and 43 were considered anterior location), patient's sex, age of the patient at the implant insertion surgery, number of days until failure, time between loss of an implant and replacement by another one, and follow-up time. Bone quantity and quality of the treated jaws were classified at the time of surgery according to the Lekholm and Zarb (1985) classification.
General health and behavioral history were collected from the patients' files. The presence of a medicament list in the patients' records was used to correlate the use of certain drugs to specific health conditions. The following health factors were assessed: diabetes type I or II, hypertension, hypercholesterolemia, hypothyroidism, asthma, psoriasis, chemotherapy, and irradiation of the head-neck region. The patients were also classified according to the intake of the following medication types: antidepressants, immunosuppressive drugs, bisphosphonates, antithrombotic agents (antiplatelet, anticoagulant, thrombolytic drugs), hormone replacement therapy in women, and medicaments to reduce gastric acid production. The following behavioral factors were assessed: smoking habits, use of snuff, bruxism.
Statistical Analyses
The mean, standard deviation, and percentages were presented as descriptive statistics. Logistic regression models were used at the patient level as well as the implant level. The patientlevel analysis considered the patient as the statistical unit, with patients presenting or not presenting implant failures. Regression at the patient level was used to evaluate the effect of explanatory health variables on the failure of implants up to abutment connection-that is, health factors that are inherently associated to the patient, not to the implant. First, a univariate effect of each health factor on the implant failure was evaluated. Odds ratios and their 95% confidence intervals were computed. The Wald test based on robust standard errors was used to assess the significance of each factor. A factor was excluded from further multivariate analysis if the univariate logistic regression resulted in a clearly nonsignificant odds ratio (P > 0.1). In the second step, a multivariate logistic regression gave the effects on different risk factors when controlling for other factors. The results of the final model were presented as an estimated odds ratio of each significant prognostic variable (P < 0.05).
An implant-level model having the implant as the statistical unit was performed to assess the effects of the implant-related and local bone factors on the failure of implants up to abutment connection, also including the health variables. A generalized estimating equation (GEE) method was used to account for the fact that repeated observations (several implants) were available for a single patient. Because the outcomes relating to implants within a single patient must be more closely correlated to each other than the outcomes of implants in separate patients, ignoring these correlations could result in a bias in P value computations (Shintani 2014) . All models were adjusted for clustering of subject and implants in a binary logistic regression model through GEE with a binomial distribution and a logit link function, while assuming an exchangeable working correlation structure to assess the relationship between implant failure up to abutment connection (dependent variable) and the risk factors (independent variables). Initially, a univariate GEE on each variable was performed. To verify multicollinearity, a correlation matrix of all predictor variables with a significant odds ratio (P value cutoff point of 0.1) identified in the univariate GEE was scanned to see whether there were some high correlations among the predictors. Collinearity statistics obtaining variance inflation factor and tolerance statistic were also performed to detect more subtle forms of multicollinearity. Then, a multivariable model with a forced entry method was used to evaluate the effect of the factors that were univariately significant (P < 0.1) and did not present multicollinearity. A Wald chi-square test was used to analyze the statistical significance of each parameter within the model. The results of the final model were presented as an estimated odds ratio of each significant prognostic variable (P < 0.05).
All data were statistically analyzed with SPSS 22 (SPSS Inc.).
Results
Overall, 642 of 10,096 implants (6.36%) failed. From this total of 642 lost implants, 176 implants in 139 patients were lost up to the second-stage surgery (65 men and 74 women; mean age at the time of implant surgery, 54.1 ± 16.3 y; minimum, 17.7 y; maximum, 90.1 y). This corresponds to a failure rate up to abutment connection of 1.74% at the implant level and 5.21% at the patient level. The location of the implants was as follows: 73 in the anterior maxilla, 36 in the anterior mandible, 44 in the posterior maxilla, and 23 in the posterior mandible. Only 4 of the 176 failures up to the abutment connection occurred in nonsubmerged implants with a delayed loading protocol. Table 1 shows a comparison of groups of implants failed up to and after abutment connection according to the distribution of implants with regard to the Lekholm and Zarb (1985) classification of bone quantity and quality. Note that the distribution of implants in sites of different bone quantities and qualities was quite similar between the groups.
The univariate binary logistic regression showed that the following predictors had a statistically significant odds ratio at the patient level (Table 2) : smoking (P < 0.001), number of cigarettes per day (P = 0.002), the intake of antidepressants (P = 0.002), and age of the patient at the time of the surgery (P = 0.001). After only the variables with a statistically significant odds ratio were included in the multivariate binary logistic regression model (Table 3) , smoking (P = 0.003) and the intake of antidepressants (P = 0.009) continued to present a statistically significant odds ratio. The univariate GEE model showed that the following predictors had a statistically significant odds ratio at the implant level (Table 4) : smoking (P < 0.001), number of cigarettes per day (P = 0.040), hypothyroidism (P = 0.065), the intake of antidepressants (P = 0.046), implant jaw location (P = 0.064), bone quantity (quantity A as the reference category; quantity C, P = 0.039; quantity D, P < 0.001; quantity E, P < 0.001), bone quality (quality 1 as the reference category; quality 4, P = 0.034), implant surface (P < 0.001), implant system (Nobel turned as the reference category; Nobel TiUnite, P = 0.002), and bone graft procedures (P = 0.009). After only the variables with a statistically significant odds ratio were included in the multivariate GEE model (Table 5) , only smoking (P = 0.022) continued to present a statistically significant odds ratio.
As none of the patients who presented a failure before abutment connection were taking bisphosphonates, this variable was not included in any statistical model.
Discussion
The aim of the present study was to assess the influence of local and systemic factors on the occurrence of implant failures up to second-stage surgery. As the study of failures only before the abutment connection limits the observation to the stage before the prosthetic treatment, confounding factors are eliminated. The regression analyses performed in this study tried to identify the factors that were possibly related to implant failure. The univariate regression assessed the relationship between each independent variable and implant failure separately, and the multivariate regression assessed the relationship of the variables that were univariately significant to implant failure, controlling for one another. In the multivariate model, only 2 variables were shown to exert some significant effect on the failures up to abutment connection: the intake of antidepressant drugs at the patient-level analysis and smoking at both the implant-and patient-level analyses.
Regarding the intake of antidepressants, there is biochemical and clinical evidence suggesting a relationship between the intake of such medicaments and the impairment of bone metabolism, which in theory could interfere with the osseointegration process. From the biochemical point of view, it is possible that neuroendocrine mechanisms related to the serotonin system could regulate osteoclast differentiation/activation According to the Lekholm and Zarb (1985) classification, bone quality is broken into 4 groups per the proportion and structure of compact and trabecular bone tissue: type 1, large homogeneous cortical/compact bone; type 2, thick layer of compact bone surrounding a dense trabecular bone; type 3, thin cortical layer surrounding a dense trabecular bone; type 4, thin cortical layer surrounding a core of low-density trabecular bone. The quantity of jawbone is broken into 5 groups (A-E) based on the residual jaw shape following tooth extraction: bone classified as A presents the largest amount of bone among all classes, whereas bone classified as E presents the lowest volume of bone. a Missing information of bone quantity and quality: 11 implants. b Missing information of bone quantity and quality: 12 implants.
because osteoclasts derive from hematopoietic cell precursors and a relationship between bone and the immune system has been established (Gruber 1991; Bab and Einhorn 1993; Ershler et al. 1997) . Studies have identified a functional serotonin system in osteoblasts and osteoclasts (Bliziotes et al. 2001; Westbroek et al. 2001; Battaglino et al. 2004 ) in which the serotonin transporter and several receptors are expressed in osteoblasts as well as osteoclasts (Bliziotes et al. 2001; Westbroek et al. 2001) . The presence of serotonin receptors and the serotonin transporter in bone raises the question whether medications that antagonize serotonin reuptake could influence bone metabolism. Peripheral serotonin signaling directly activates osteoblastic serotonin receptors to inhibit bone formation. Central serotonin signaling inhibits the sympathetic nervous system, thus alleviating the negative adrenergic tone on osteoblasts. In the situation of elevated serotonin levels that result from treatment with SSRIs (i.e., selective serotonin reuptake inhibitors-a class of antidepressant drugs), the negative skeletal effects of peripheral serotonin may outweigh the positive skeletal benefits resulting from the enhanced central serotonin antidepressant and antisympathetic activity (Ducy and Karsenty 2010) .
In vitro studies have shown that activity of the serotonin transporter is required for osteoclast differentiation. While blockage of the serotonin transporter reduced osteoclast differentiation when fluoxetine, an antidepressant, was administered to produce micromolar (μM) concentrations (Battaglino et al. 2004; Gustafsson et al. 2006) , there was an increase in osteoclast differentiation for the same medicament in the nanomolar (nM) concentrations (Gustafsson et al. 2006) . In vivo studies demonstrated detrimental effects of fluoxetine on trabecular architecture (Warden et al. 2008 ) and bone mineral density (Warden et al. 2005; Warden et al. 2008 ) in mice. Another in vivo study showed that serotonin acts on osteoblasts, inhibiting their proliferation (Yadav et al. 2008) . These studies in animal models indicate a negative effect of SSRIs on bone mass and suggest that these antidepressants may possess direct antianabolic skeletal effects through the pharmacologic inhibition of the serotonin transporter.
From the clinical point of view, an association between antidepressants and decreased bone mineral density in humans has been suggested (Cauley et al. 2005; Richards et al. 2007; Williams et al. 2008) . Moreover, bone mass has been shown to Only the patient and health factors that were considered statistically significant (P < 0.1) in the univariate model and did not present multicollinearity were included in the multivariate model. 95% CI, 95% confidence interval; OR, odds ratio. The information for some conditions is unknown for a variable number of implants. remain negatively associated with not only clinical depression but also depressive symptoms (Robbins et al. 2001; Williams et al. 2011) . Bone quality has also been shown to be reduced among men and younger women with a history of mood disorders (Williams et al. 2013) .
In some studies, smoking has been associated with depression (Escobedo et al. 1998; Hall et al. 1993 ). In the present study, smoking was identified as the other predictor to exert some statistically significant effect on the failures up to abutment connection. A recent meta-analysis analyzing >100 studies has shown that failures of implants inserted into smokers are 2.23 times more likely to happen than failures of implants inserted into nonsmokers (Chrcanovic et al. 2015) . The increase of implant failure rates due to smoking is hypothesized to be related mainly to the effect of smoking in osteogenesis and angiogenesis (Ma et al. 2010) . Concerning the effects on osteogenesis, Ma et al. (2011) showed that nicotine inhibited the gene expression of BMP-2, TGF-b1, PDGF-AA, and VEGF in osteoblasts. BMP-2 is the most potent osteogenic induction factor regulating osteoblast differentiation, ALP expression, and subsequent mineralization (Rawadi et al. 2003) . TGF-b1 is produced by osteoblasts and incorporated into the bone matrix. During bone remodeling, TGF-b1 plays an important role in the regulation of osteoblast proliferation, differentiation, and apoptosis, with subsequent important effects on bone formation and remodeling (Deng et al. 2008) . PDGF and VEGF have angiogenic effects during bone healing (De la Riva et al. 2010) . Whereas their expression can be detected in osteoblasts, they are considered to be able to regulate osteoblast activity as well. VEGF can interact synergistically with bone morphogenetic protein to promote skeletal development and bone healing by enhancing cell recruitment, prolonging cell survival, and increasing angiogenesis (Patel et al. 2008) . Bone morphogenetic protein acts as an important regulator that stimulates production of VEGF in osteoblasts (Samee et al. 2008) . Therefore, the inhibitive effect of nicotine on osteoblastic activity may contribute to the failure of dental implant osseointegration (Ma et al. 2011 ).
In addition, some studies showed that osteogenesis and angiogenesis are tightly coupled during bone formation and that angiogenesis plays a pivotal role in skeletal development and bone repair (Fang et al. 2005) . Besides carrying oxygen and nutrients to bone tissue, blood flow plays an active role in bone formation and remodeling by mediating the interactions among osteoblasts, osteocytes, osteoclasts, and vascular cells at a variety of levels (Fleming et al. 2001) . The deleterious effects of smoking have been shown on not only osteoblasts but also microcirculation-including morphologic aspects, particularly vessel wall injury and capillary loss, as well as functional aspects, predominantly changes in tissue perfusion and its regulatory mechanisms, notable reactive hyperemia, and sequestration of blood cells in the microcirculation (Lehr 2000) . Studies (Ma et al. 2007; Ma et al. 2010 ) demonstrated that nicotine exposure has direct effects on blood vessels, producing vasoconstriction and systemic venoconstriction, which decrease blood perfusion and cause low oxygen and ischemia-the major stimulus for initiating the angiogenic cascade (Wang et al. 2007 ). Hypoxia and ischemia owing to nicotine exposure could stimulate HIF-1α expression, leading to an increased expression of VEGF, which in turn stimulates angiogenesis. However, the enhanced vessel formation is incapable of compensating for the adverse effect of the reduced blood flow possibly caused by nicotine-induced vasoconstriction (Ma et al. 2010 ). Even though the increased expression of VEGF caused by hypoxia and ischemia may stimulate angiogenesis, it may also contribute to compromised bone healing because excessive VEGF may lead to impairment in bone formation-possibly by promoting mesenchymal stem cell differentiation toward an endothelial lineage (Kon et al. 2001) , consequently reducing the availability of mesenchymal stem cells for osteogenic differentiation (Keramaris et al. 2008) . Alternatively, excessive VEGF may increase recruitment of osteoclasts into the bone regeneration sites and lead to an excessive bone resorption (Keramaris et al. 2008) . Another fact that should be taken into consideration is that the inflammatory response to bone trauma plays an important role in initiating the repair cascade. The trauma activates downstream factors (e.g., cytokines and growth factors) that recruit osteoprogenitor and mesenchymal cells to the injury site (Kon et al. 2001; Mountziaris and Mikos 2008) . The problem is that nicotine is an anti-inflammatory agent (Geng et al. 1996) .
Concerning the bone quantity and quality of the implant site, as the distribution of implants that failed up to abutment connection was similar to the implants failing after this procedure, poor bone was not likely a determinant factor to influence an early failure for the patients of the present study.
The limitations of the present study include that it is a retrospective study, which inherently results in flaws. These problems were manifested by the gaps in information and incomplete records. As all data rely on the accuracy of the original examination and documentation, items may have been excluded in the initial examination or not recorded in the dental/ medical chart. The lack of specific information characterizing the statuses of the patients' systemic conditions and the dosages of their medications is a limitation also connected to the retrospective nature of this study. It is also important to stress that the different classes of antidepressants were prescribed to patients of the present study. Antidepressants are a large family of drugs, which have different biological properties and mechanisms of action that might have differently affected the bone metabolism and, consequently, the failures of dental implants. The present results might be applicable to the general population, since all patients ever treated with dental implants in the clinic were included in the database from which the implants with early failures were analyzed. No patient was excluded, regardless of any health or other condition. For that reason, selection bias was also minimized. Only the factors that were considered statistically significant (P < 0.1) in the univariate model and did not present multicollinearity were included in the multivariate model. 95% CI, 95% confidence interval; OR, odds ratio.
Conclusion
Smoking and the intake of antidepressants are suggested to be potential influencing factors to the occurrence of implant failures up to abutment connection.
